4.7961
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché EKSO Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$4.65
Aprire:
$4.63
Volume 24 ore:
16,621
Relative Volume:
0.13
Capitalizzazione di mercato:
$12.58M
Reddito:
$18.28M
Utile/perdita netta:
$-15.20M
Rapporto P/E:
-4.3601
EPS:
-1.1
Flusso di cassa netto:
$-12.21M
1 W Prestazione:
-0.50%
1M Prestazione:
+6.82%
6M Prestazione:
+24.25%
1 anno Prestazione:
-50.03%
Ekso Bionics Holdings Inc Stock (EKSO) Company Profile
Nome
Ekso Bionics Holdings Inc
Settore
Industria
Telefono
510-984-1761
Indirizzo
101 GLACIER POINT, SAN RAFAEL
Confronta EKSO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
EKSO
Ekso Bionics Holdings Inc
|
4.7961 | 12.20M | 18.28M | -15.20M | -12.21M | -1.10 |
|
ISRG
Intuitive Surgical Inc
|
554.37 | 198.35B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
195.95 | 57.11B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
78.92 | 38.90B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
247.99 | 36.94B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
WST
West Pharmaceutical Services Inc
|
267.09 | 19.56B | 2.96B | 487.70M | 344.00M | 6.6758 |
Ekso Bionics Holdings Inc Stock (EKSO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2016-10-14 | Iniziato | SunTrust | Buy |
Ekso Bionics Holdings Inc Borsa (EKSO) Ultime notizie
Ekso Bionics (NASDAQ:EKSO) Raised to “Hold” at Wall Street Zen - Defense World
Ekso Bionics (EKSO) CFO Wong sells $5,818 in stock By Investing.com - Investing.com Nigeria
Ekso Bionics (EKSO) COO Jones sells $1269 in stock By Investing.com - Investing.com Nigeria
Ekso Bionics (EKSO) CFO Wong sells $5,818 in stock - Investing.com
Ekso Bionics (EKSO) COO Jones sells $1269 in stock - Investing.com India
Ekso Bionics to distribute MediTouch’s BalanceTutor in US market By Investing.com - Investing.com Canada
Ekso Bionics jumps 20% after securing exclusive US distribution rights for BalanceTutor system - MSN
Why Ekso Bionics Holdings Inc. (23E0) stock attracts HNW investors2025 Technical Patterns & Free Community Supported Trade Ideas - Newser
Ekso Bionics Faces Market Challenges Amid Financial Struggles - timothysykes.com
Ekso Bionics Inks Agreement to Become the Exclusive U.S. Distributor of MediTouch's BalanceTutor Rehabilitation System - marketscreener.com
Ekso Bionics to distribute MediTouch’s BalanceTutor in US market - Investing.com
Ekso Bionics stock soars after becoming exclusive U.S. distributor for BalanceTutor - Investing.com
Ekso Bionics inks agreement to become the exclusive U.S. distributor of Meditouch's groundbreaking BalanceTutor rehabilitation system - marketscreener.com
Ekso Bionics Partners with MediTouch to Distribute BalanceTutor Rehabilitation System in the U.S. - Quiver Quantitative
Ekso Bionics Inks Agreement to Become the Exclusive U.S. - GlobeNewswire
What MACD trends signal for Ekso Bionics Holdings Inc. (23E0) stock2025 Geopolitical Influence & Detailed Earnings Play Alerts - Newser
Is Ekso Bionics Holdings Inc. (23E0) stock suitable for passive index fundsTrade Risk Assessment & Capital Efficiency Focused Ideas - Newser
Why global investors buy Ekso Bionics Holdings Inc. (23E0) stockJuly 2025 Highlights & Community Supported Trade Ideas - Newser
Competitive Technologies (OTCMKTS:CTTC) versus Ekso Bionics (NASDAQ:EKSO) Critical Survey - Defense World
Will Ekso Bionics Holdings Inc. stock reach Wall Street targets2025 Trading Volume Trends & Stock Timing and Entry Methods - Newser
Is Ekso Bionics Holdings Inc. stock a safe investment in uncertain markets2025 Price Momentum & Precise Entry and Exit Recommendations - moha.gov.vn
How Recent Moves Are Rewriting the Story for Ekso Bionics - Yahoo Finance
Physical AI Market Size to Expand at 31.26% CAGR, to Capture USD 61.19 Billion 2034 - GlobeNewswire Inc.
Human Augmentation Market Covering Prime Factors - openPR.com
Ekso Bionics (EKSO) Upgraded to Buy: Here's Why - sharewise.com
How forex fluctuations impact Ekso Bionics Holdings Inc. (23E0) stock2025 Buyback Activity & Reliable Entry Point Alerts - newser.com
Why Ekso Bionics Holdings Inc. (23E0) stock could rally stronglyPortfolio Value Summary & Expert Verified Movement Alerts - newser.com
What is the fair value estimate for Ekso Bionics Holdings Inc. (23E0) stock in 2025Market Sentiment Summary & Smart Investment Allocation Tips - newser.com
Will Ekso Bionics Holdings Inc. (23E0) stock benefit from sector leadershipJuly 2025 Fed Impact & Free Verified High Yield Trade Plans - newser.com
Ekso Bionics Q2 2025 slides: Personal exoskeleton focus amid 58% revenue drop - Investing.com Nigeria
Earnings call transcript: Ekso Bionics Q2 2025 sees revenue drop, stock rises By Investing.com - Investing.com South Africa
Earnings call transcript: Ekso Bionics Q2 2025 sees revenue drop, stock rises - Investing.com Australia
Is Ekso Bionics Holdings Inc. stock vulnerable to regulatory risks - newser.com
Is Ekso Bionics Holdings Inc. (23E0) stock a fit for income portfoliosSwing Trade & Free Expert Verified Stock Movement Alerts - newser.com
Will Ekso Bionics Holdings Inc. (23E0) stock profit from fiscal stimulusIPO Watch & Low Drawdown Investment Strategies - newser.com
H.C. Wainwright raises Ekso Bionics stock price target to $6 on sales recovery - Investing.com Australia
Ekso Bionics Holdings Inc Azioni (EKSO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Ekso Bionics Holdings Inc Azioni (EKSO) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Wong Jerome | Chief Financial Officer |
Dec 09 '25 |
Sale |
4.70 |
1,238 |
5,819 |
24,771 |
| Wong Jerome | Chief Financial Officer |
Nov 10 '25 |
Sale |
4.80 |
11,288 |
54,182 |
26,009 |
| Jones Jason C | Chief Operating Officer |
Nov 10 '25 |
Sale |
4.80 |
9,723 |
46,670 |
27,211 |
| Davis Scott G. | CEO |
Nov 10 '25 |
Sale |
4.80 |
23,315 |
111,912 |
78,777 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):